The COlchicine HypERtENsion Trial

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 150 participants.

Also called NCT04916522

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04916522
  • EudraCT 2020-004492-40
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04916522. Randomized; double masking; primary purpose treatment. Start 2021-08-10 (actual); primary completion 2026-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The COlchicine HypERtENsion Trial
Acronym
COHERENT
Condition
Hypertension
Intervention (Drug)
Colchicine
Intervention (Drug)
Placebo
Lead sponsor
Herlev and Gentofte Hospital (class: other)
Collaborator
University of Copenhagen (class: other)

Record details

Record id
cardio:ct-nct04916522
Content hash
17dbe9925798aa2c5fbac588212e513c570a6287b9bba79b117af4379e91ca1f